Genus PLC - Asset Resilience Ratio

Latest as of December 2023: -1.07%

Genus PLC (GNS) has an Asset Resilience Ratio of -1.07% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read GNS total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

GBX-11.30 Million

≈ $-1.37K USD Cash + Short-term Investments

Total Assets

GBX1.05 Billion

≈ $128.23K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2023)

This chart shows how Genus PLC's Asset Resilience Ratio has changed over time. See shareholders equity of Genus PLC for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Genus PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Genus PLC (GNS) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX-11.30 Million	-1.07%
Total Liquid Assets	GBX-11.30 Million	-1.07%

Asset Resilience Insights

Limited Liquidity: Genus PLC maintains only -1.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Genus PLC Industry Peers by Asset Resilience Ratio

Compare Genus PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Genus PLC (2006–2023)

The table below shows the annual Asset Resilience Ratio data for Genus PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-06-30	-1.30%	GBX-13.10 Million ≈ $-1.59K	GBX1.01 Billion ≈ $122.58K	-0.24pp
2022-06-30	-1.06%	GBX-10.80 Million ≈ $-1.31K	GBX1.02 Billion ≈ $123.85K	-0.85pp
2021-06-30	-0.21%	GBX-1.80 Million ≈ $-219.01	GBX851.00 Million ≈ $103.54K	0.00pp
2020-06-30	-0.21%	GBX-1.80 Million ≈ $-219.01	GBX855.40 Million ≈ $104.08K	-0.53pp
2018-06-30	0.32%	GBX2.50 Million ≈ $304.18	GBX789.20 Million ≈ $96.02K	+0.15pp
2017-06-30	0.16%	GBX1.30 Million ≈ $158.17	GBX797.60 Million ≈ $97.04K	+0.08pp
2016-06-30	0.08%	GBX600.00K ≈ $73.00	GBX739.10 Million ≈ $89.93K	-0.03pp
2015-06-30	0.11%	GBX700.00K ≈ $85.17	GBX644.30 Million ≈ $78.39K	+0.18pp
2012-06-30	-0.07%	GBX-400.00K ≈ $-48.67	GBX588.20 Million ≈ $71.57K	+0.10pp
2010-06-30	-0.17%	GBX-900.00K ≈ $-109.50	GBX542.40 Million ≈ $65.99K	+0.18pp
2009-06-30	-0.34%	GBX-1.70 Million ≈ $-206.84	GBX497.90 Million ≈ $60.58K	+0.23pp
2008-06-30	-0.57%	GBX-2.50 Million ≈ $-304.18	GBX436.00 Million ≈ $53.05K	+0.46pp
2007-06-30	-1.03%	GBX-4.50 Million ≈ $-547.52	GBX434.80 Million ≈ $52.90K	-0.38pp
2006-06-30	-0.66%	GBX-3.00 Million ≈ $-365.01	GBX456.30 Million ≈ $55.52K	--

pp = percentage points

About Genus PLC

LSE:GNS UK Biotechnology

Market Cap

$19.04 Million

GBX156.47 Billion GBX

Market Cap Rank

#25174 Global

#254 in UK

Share Price

GBX2356.00

Change (1 day)

+0.51%

52-Week Range

GBX1924.00 - GBX3170.00

All Time High

GBX5805.43